Case Report {#sec1_1}
===========

A 10-year-old female patient was referred to our Dermoscopy Ambulatory because of a new pigmented lesion noted 6 months before. She was receiving treatment for dystrophic bullous epidermolysis in a Pediatric Hospital. Her mother reported progressive growth and color change of this lesion since its appearance. In clinical examination, the patient presented pseudosyndactily and sparse exulcerations in the areas of previous bullae. In the submandibular area, an irregular pigmented mole of about 2 cm in diameter was observed (**fig. [1](#F1){ref-type="fig"}**). Dermoscopy showed a multicomponent pattern, with multiple colors, ill-defined network, black blotches, streaks, multiple dots, a blue-whitish veil and granularity at the periphery (**fig. [2](#F2){ref-type="fig"}**). Due to the possibility of a bullous epidermolysis nevi, the authors decided to follow up clinically and with dermoscopy every 6 months. This follow-up was delayed due to infectious complications of the disease, leading to hospitalization of the child.

Discussion {#sec1_2}
==========

Epidermolysis bullosa (EB) represents a heterogeneous group of mechano-bullous disorders genetically rooted in an intrinsic defect of the structural components of the basement membrane zone \[[@B1]\]. The development of lesions with atypical clinical features in patients with different forms of EB has occasionally been pointed out. The recessive variants of the disease account for the vast majority of the reported cases.

There are a few reports in the literature of moles suspicious of malignancy in patients with bullous epidermolysis, recently classified in a new entity named EB nevi. They commonly arise in areas of previous bullae or erosions, tend to present rapid growth, and usually fulfill the clinical ABCD criteria for atypical or malignant melanocytic proliferations. These nevi are dynamic, beginning as flat pigmented lesions and becoming papillated, loosing pigment or even becoming more pigmented. So far, no evolution to malignancy has been described, but the number of EB nevi studied is not large enough to completely rule out the possibility that they might be melanoma precursor lesions.

Two pathogenic theories about the development of EB nevi have been proposed. According to one of them, the repetitive disruption of the basement membrane leads single melanocytes or local nevus cells to break senescence and undergo proliferation \[[@B2], [@B3]\]. According to the other theory, viable melanocytes/nevus cells freely float the cavity of an EB blister \[[@B4]\] and, after settling down, proliferate excessively in the microenvironment of epidermal regeneration in an arbitrary arrangement \[[@B5], [@B6], [@B7]\]. Cytokines and growth factors, such as interleukin 8, granulocyte-macrophage colony-stimulating factor, prostaglandin E2 and leukotriene B4 have been detected in blister fluid \[[@B7]\], which might potentiate melanocytic proliferation. Understanding the pathogenesis may help disclose their benign nature, in spite of false-positive scores with application of dermoscopic algorithms.

Interestingly, EB nevi show analogy to recurrent nevi after incomplete surgical excision or trauma of a nevus. Such traumatized moles also frequently mimic melanoma, clinically, dermoscopically and histologically. While dermoscopy and, more recently, reflectance confocal microscopy (RCM) have proven to be valuable tools in the diagnosis of most pigmented lesions, little is currently known about their clinical value in the differential diagnosis of recurrent melanocytic proliferations. Longo et al. \[[@B8]\] investigated dermoscopic and RCM features of seven histopathologically diagnosed cases of recurrent melanocytic proliferations. Repigmentation occurring within the scar through dermoscopy was a clue suggestive for nevi, while a lateral spreading of the pigmentation, extending from the border of the scar towards the surrounding normal skin was observed in all cases of melanoma. Although scar pigmentation is a frequent phenomenon, there are few papers on this subject \[[@B9]\]. Yoshida et al. \[[@B10]\] reported the case of a 47-year-old patient with a mole on her left arm since childhood, where a darker pigmentation had been observed. Through dermoscopy a starburst pattern was seen, and histopathology diagnosed a melanocytic nevus with partial recurrence after minor trauma. Similarly to what happens in EB nevi, it was speculated that stimulation of melanin production might have been induced in the wound healing process.

Lanschuetzer et al. \[[@B11]\] used dermoscopy to test usefulness of this technique in distinguishing EB nevi from melanoma. Twenty-three nevi of 11 patients were analyzed with a dermoscope. Twenty of the 23 lesions were classified as having a multicomponent pattern or showed a 3-structure type pattern, both highly suggestive of malignant melanoma. More than half of the lesions achieved a high score for the ABCD and 7-point checklist. Nevertheless, strong morphologic indicators for invasive cutaneous melanoma, or a blue-whitish veil, which represents a melanoma-induced acanthotic epidermis, were not observed. Although it was often possible to estimate the benign nature of the moles, unequivocal discrimination from melanoma could not be made, and regular follow-up was proposed.

Schiffner et al. \[[@B12]\] proposed a progression model of lentigo maligna located on the face. According to their findings, slate-gray dots are an early feature of lentigo maligna, which can increase to globules. Short streaks can be detected, and can progress to very specific rhomboidal structures. Melanoma cells within the follicles can invade the adjacent dermis, resulting in bizarre globules at the periphery of the follicle. During further tumor progression, rhomboidal structures become broader and hair follicles are obliterated.

Taking into account all the aspects of EB nevi described above, it can be considered an exception among melanocytic lesions. If not aware of this particular nevi, clinicians might be tempted to establish a more aggressive treatment, when clinical and dermoscopic semestral review would be a secure and more convenient therapeutic strategy for these fragile skin patients. Here dermoscopy presents as an essential technique to prevent overtreatment.
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